Melissa Vonder Haar

CBD Regulatory Roundup: Fall 2021

Edibles allowed, Delta-8 banned and more from the state and national levels

FDA Hesitant to Define CBD as ‘Dietary Ingredient’

Sends message to the industry: Don’t worry about rules and processes

CBD Beauty Sales to Double in 2021: Report

Can the segment gain traction in convenience?

Cannabis Bill Would Also Create a Pathway for CBD

U.S. Senate remains a sticking point

Tobacco Regulatory Update

6 state, local and federal issues to watch in 2021

Behind-the-Counter Virtual Roundtable: Retailers and Suppliers Have Their Say

7 tobacco/nicotine experts discuss the category’s biggest challenges and opportunities

Behind the Counter Category Performance

Data shows cigarette rebound, vape resilience and alternative vigor

Tobacco and Nicotine Trends to Watch

CSP looks at what’s going on in all major behind-the-counter segments

Celebrating Growth Behind the Counter

All the reasons tobacco is in no jeopardy of becoming boring

U.S. Senate Introduces Bill to Legalize CBD Ingestibles

‘It’s long past time for the FDA to get with the program’

6 Beverage Companies Experimenting in CBD

Recognizing opportunity, major CPG brands are investing in cannabidiol drinks